Fifth Third Bancorp Purchases 14,097 Shares of iShares Biotechnology ETF $IBB

Fifth Third Bancorp boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 106.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 27,352 shares of the financial services provider’s stock after acquiring an additional 14,097 shares during the quarter. Fifth Third Bancorp owned approximately 0.06% of iShares Biotechnology ETF worth $4,618,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $25,000. Basepoint Wealth LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $26,000. Cary Street Partners Financial LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $29,000. Copia Wealth Management bought a new stake in iShares Biotechnology ETF in the fourth quarter worth $34,000. Finally, Caitlin John LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth $34,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.1%

IBB opened at $189.76 on Friday. The stock has a 50-day moving average of $177.79 and a 200-day moving average of $173.40. iShares Biotechnology ETF has a 52-week low of $128.84 and a 52-week high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. This represents a $0.10 annualized dividend and a yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.